Cargando…

Ventricular global function index is associated with clinical outcomes in pediatric pulmonary hypertension

BACKGROUND: Multiple right ventricular (RV) metrics have prognostic value in pulmonary hypertension (PH). A cardiac magnetic resonance imaging (CMR) derived global ventricular function index (GFI) provided improved prediction of composite adverse outcome (CAO) in adults with atherosclerosis. GFI has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ta, Hieu T., Critser, Paul J., Schäfer, Michal, Ollberding, Nicholas J., Taylor, Michael D., Di Maria, Michael V., Hirsch, Russel, Ivy, D. Dunbar, Frank, Benjamin S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316558/ https://www.ncbi.nlm.nih.gov/pubmed/37400886 http://dx.doi.org/10.1186/s12968-023-00947-8

Ejemplares similares

Factors leading to supranormal cardiac index in pediatric pulmonary hypertension patients treated with parenteral prostanoid therapy
por: Miles, Kimberley G., et al.
Publicado: (2023)

Modified Ventricular Global Function Index Correlates With Exercise Capacity in Repaired Tetralogy of Fallot
por: Ta, Hieu T., et al.
Publicado: (2020)

Balloon atrial septostomy as initial therapy in pediatric pulmonary hypertension
por: Critser, Paul J., et al.
Publicado: (2020)

Left ventricular torsion rate and the relation to right ventricular function in pediatric pulmonary arterial hypertension
por: Dufva, Melanie J., et al.
Publicado: (2018)

Cardiovascular magnetic resonance imaging derived septal curvature in neonates with bronchopulmonary dysplasia associated pulmonary hypertension
por: Critser, Paul J., et al.
Publicado: (2020)

Echocardiography in Pediatric Pulmonary Hypertension
por: Jone, Pei-Ni, et al.
Publicado: (2014)

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension
por: Ivy, D. Dunbar, et al.
Publicado: (2019)

Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension
por: Evers, Patrick D., et al.
Publicado: (2022)

Biomarkers for Pediatric Pulmonary Arterial Hypertension – A Call to Collaborate
por: Colvin, Kelley L., et al.
Publicado: (2014)

Circulating Cytokines and Growth Factors in Pediatric Pulmonary Hypertension
por: Duncan, Mark, et al.
Publicado: (2012)

Pulmonary arterial banding in mice may be a suitable model for studies on ventricular mechanics in pediatric pulmonary arterial hypertension
por: Dufva, Melanie J., et al.
Publicado: (2021)

Pediatric Pulmonary Hypertension: Insulin Like Growth Factor Binding Protein 2 is a novel marker associated with disease severity and survival
por: Griffiths, Megan, et al.
Publicado: (2020)

Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway
por: Beghetti, Maurice, et al.
Publicado: (2019)

Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension
por: Daly, Caroline M., et al.
Publicado: (2021)

Risk Assessment and Monitoring of Right Ventricular Function in Congenital Diaphragmatic Hernia
por: Critser, Paul J., et al.
Publicado: (2020)

Pulmonary Hypertension in the Population with Down Syndrome
por: Bush, Douglas S., et al.
Publicado: (2022)

Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers
por: Nawaytou, Hythem, et al.
Publicado: (2021)

Novel left ventricular mechanical index in pulmonary arterial hypertension
por: Ichimura, Kenzo, et al.
Publicado: (2023)

Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children
por: Frank, Benjamin S., et al.
Publicado: (2018)

Left ventricular vorticity is marker of ventricular interdependency in pulmonary arterial hypertension
por: Fenster, Brett, et al.
Publicado: (2015)

Repolarization Dispersion Is Associated With Diastolic Electromechanical Discoordination in Children With Pulmonary Arterial Hypertension
por: Schäfer, Michal, et al.
Publicado: (2022)

Short‐Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4‐Dimensional–Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension
por: Schäfer, Michal, et al.
Publicado: (2021)

Combined CMR and catheterization data in determining right ventricular-arterial coupling in children and adolescents with pulmonary arterial hypertension
por: Truong, Uyen, et al.
Publicado: (2014)

Non-invasive determination by cardiovascular magnetic resonance of right ventricular-vascular coupling in children and adolescents with pulmonary hypertension
por: Truong, Uyen, et al.
Publicado: (2015)

Ventricular–vascular coupling is predictive of adverse clinical outcome in paediatric pulmonary arterial hypertension
por: Dufva, Melanie J, et al.
Publicado: (2021)

Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network
por: Handler, Stephanie S., et al.
Publicado: (2022)

Circulating miRNAs in Pediatric Pulmonary Hypertension Show Promise as Biomarkers of Vascular Function
por: Kheyfets, Vitaly O., et al.
Publicado: (2017)

Bronchopulmonary dysplasia from chest radiographs to magnetic resonance imaging and computed tomography: adding value
por: Higano, Nara S., et al.
Publicado: (2022)

Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources
por: Geva, Alon, et al.
Publicado: (2019)

Evaluation of Circulating Proteins and Hemodynamics Towards Predicting Mortality in Children with Pulmonary Arterial Hypertension
por: Wagner, Brandie D., et al.
Publicado: (2013)

Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee
por: Adatia, Ian, et al.
Publicado: (2013)

Segmental Pulmonary Hypertension in Children with Congenital Heart Disease
por: Das, Bibhuti B., et al.
Publicado: (2020)

Magnetic resonance phase contrast imaging in children with pulmonary artery hypertension
por: Fonseca, Brian, et al.
Publicado: (2009)

Activation of the unfolded protein response is associated with pulmonary hypertension
por: Yeager, Michael E., et al.
Publicado: (2012)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study
por: Ivy, Dunbar, et al.
Publicado: (2021)

Non-invasive global myocardial work index as a new surrogate of ventricular-arterial coupling in hypertensive patients with preserved left ventricular ejection fraction
por: Duan, Qin, et al.
Publicado: (2022)

Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension
por: Barst, Robyn J., et al.
Publicado: (2012)

A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011
por: del Cerro, Maria Jesus, et al.
Publicado: (2011)

A unique gut microbiota signature in pulmonary arterial hypertension: A pilot study
por: Jose, Arun, et al.
Publicado: (2022)

Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine
por: Douwes, Johannes M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bpsc4mshqfnt7ft5ung8hkm6qb